Companies › PHGE

BiomX Inc (PHGE)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001739174 · EDGAR filings · Updated 2026-07-28

BiomX Inc (PHGE) has reported institutional ownership of 3.1%, with 13 institutional managers holding positions valued at $1.19M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — Current report (8-K) filed
• 2026-07-27 — Prospectus supplement (424B5) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-17 — PRE 14A filed
• 2026-07-14 — Prospectus supplement (424B3) filed
• 2026-07-13 — EFFECT filed
• 2026-07-10 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BiomX Inc has 13 institutional holders and institutional ownership of 3.1%.

Insider activity

Insiders reported 14 transactions (0 buys, 4 sells) across 4 reporting insiders, with a net reported value of −$8.25M.

Data flags from SEC filings

Related companies

CDT EQUITY INC (CDT) · MILESTONE SCIENTIFIC INC (MLSS) · ANBIO BIOTECHNOLOGY (NNNN) · PULSENMORE LTD (PLSM) · Lexaria Bioscience Corp (LEXX) · IGC PHARMA INC (IGC)